Growdon ME, et al. – Because prescription drug spending accounts for a growing share of US healthcare costs—and spending can be reduced by replacing generic drugs for identical brand-name drugs or for brand-name drugs with similar effect—researchers calculated the potential cost savings for Medicare from generic substitution and therapeutic interchange of ACEIs and ARBs.